国际医疗器械设计与制造技术展览会

Dedicated to design & manufacturing for medical device

September 24-26,2025 | SWEECC H1&H2

EN | 中文
   

Zeus Debuts PTFE Sub-Lite-Wall Multi-Lumen Tubing & More Supplier News

Zeus Industrial Products Inc. is offering new PTFE Sub-Lite-Wall multi-lumen tubing in numerous configurations for steerable catheters. Zeus has manufactured multi-lumen tubing with unique profiles and multiple working channels that run the entire length of the tubing and is now extending those multi-lumen extrusion capabilities to include ultra-thin walls.

Zeus can produce PTFE Sub-Lite-Wall multi-lumens with average max wall thicknesses ranging from 0.002 to 0.005 in. (0.051 mm to 0.127 mm). In addition to ultra-thin walls, the new product features high structural integrity, improved planarity, high lubricity, and excellent dielectric strength. It is biocompatible (certified USP Class VI) and has a working temperature of 260 °C (500 °F), the company shared in a news release.

“Manufacturing steerable catheters is a challenging and time-consuming process, especially when manufacturers have to procure and bundle several individual liners into a final catheter assembly. This delicate process also increases the risk of production and device failures,” explained Rodrigo Silva, product manager, Zeus. “Zeus eliminates these obstacles by providing a single PTFE Sub-Lite Wall multi-lumen liner that’s ready to go. Based on early evaluator feedback, the time to assemble a steerable catheter was greatly reduced to one-fifth of the traditional time.”

Qosina offers a line of hemostasis valves designed for use in a wide range of cardiovascular procedures. The company stocks more than 80 configurations in a variety of styles and features including Y- and straight connectors, double valves, one-handed as well as sideport tubing, and stopcocks.

Free samples are available.

P-DUKE offers high-power density 180W medical AC/DC power supplies in its MAD180 series. Suitable for medical diagnostic equipment for such as MRI scanners, laser treatment, X-ray, and patient monitoring, these power supplies can deliver up to180W and 150W at natural convection cooling, the company shared in a news release.

With forced air cooling, the supplies achieve up to 220W peak output power for 5 seconds. This series features 2XMOPP insulation and low leakage current less than100 µA, suiting it for any safety-demanding type BF medical application. Certified with EIC/EN/ANSI 60601-1, the supplies feature 2 x 3 in. open frame versions or optional encased versions and DIN-rail versions with an universal input range of 85 to 264 Vac and also especially supports 120-370Vdc input range.

This series provides 12, 15, 18, 24, 28, 36, 48, 53 Vdc single output voltage. The output voltage can be easily adjusted up to ±8% with the integrated potentiometer. The series is equipped with long-life electrolytic capacitors, efficiencies up to 94%, power factor correction is 0.95, no-load power consumption of 150mW max. and IEC protection types of class I and class II.

Beacon MedTech Solutions is partnering with Sumitomo (SHI) Demag to support increased production in its 110,000-sq-ft facility in Leominster, MA. This investment in new machinery will enable the Beacon team to further scale medical molding operations to support increased customer demand for single-use technology applications in the biopharma and life sciences markets. Following an initial installation of two SE-EV-A series injection molding machines, Beacon MedTech plans to install additional presses in the first half of 2022. According to a news release issued by Beacon MedTech, each Sumitomo (SHI) Demag presses comes standard with:

• Direct-drive servo motors on clamp and injection movements.
• Mold parallelism to ensure the mold is square and assembled correctly.
• Front flow control (FFC) to provide precision control to ensure consistent filling.
• Interchangeable screw and barrels.
• Easy integration with automation in dedicated work cells to increase efficiencies.

“Sumitomo (SHI) Demag worked directly with our technical and engineering departments to optimize the presses to meet demanding, complex medical product specifications,” said Michael McGee, president of Beacon MedTech Solutions, in the release. “This partnership will allow our team to maximize productivity while maintaining the commitment to operational efficiency that allows us to deliver the speed and responsiveness our customers expect.”

Added Bob Brady, Sumitomo (SHI) Demag medical business development manager: “Beacon MedTech Solutions is an ideal manufacturer to leverage Sumitomo (SHI) Demag’s technologically advanced injection molding equipment given its focus on complex, highly engineered parts for the medical, life sciences, and biopharma industries. We look forward to continuing to work together to specify and build additional machines that will expand capacity for high-quality, high-precision components.”

Pictured above from left are Robert Gove, Beacon MedTech Solutions senior tooling and program manager, and Bob Brady, Sumitomo Demag medical business development manager.

Portescap has opened a new engineering laboratory in its Mumbai, India office. The new lab expands the company’s analysis and reliability testing space and increases its proof of concept (POC) capabilities. The goal is to help customers quickly solve motion challenges and get products to market faster, the company reported in a news release.

Portescap engineers are equipped with the latest simulation software and accelerated life testing equipment and can apply different duty cycles, direction of load rotation, and variable loads to motors and assemblies.

An on-site environmental chamber and noise and vibration (NVH) chamber can be used to simulate real-world conditions. Portescap can also deliver rapid prototypes thanks to the lab’s advanced 3D printing and machining equipment.

Portescap has manufacturing centers in the United States and India, and it has a Global Product Development network with research and development centers in the United States, China, India, and Switzerland.

Article source: Qmed and MD+DI

X